首页> 美国卫生研究院文献>Substance Abuse Treatment Prevention and Policy >Suspension of the National Registry of Evidence-Based Programs and Practices: the importance of adhering to the evidence
【2h】

Suspension of the National Registry of Evidence-Based Programs and Practices: the importance of adhering to the evidence

机译:暂停国家循证计划和实践注册机构:坚持证据的重要性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Recently the United States Assistant Secretary of Mental Health and Substance Use disclosed having suspended the National Registry of Evidence-Based Programs and Practices, stating it was so deficient in both rigor and breadth that it must be replaced. However, a closer examination of her claims about the Registry indicates many of them to be inaccurate. Contrary to her assertions, the Registry is not devoid of medication-assisted treatments for opioid use; nor does it contain but a scant few interventions related to schizophrenia and psychosis. Moreover, many of her criticisms regarding rigor pertain to reviews completed since late 2015, when the Substance Abuse and Mental Health Services Administration altered key aspects of the Registry. In contrast to reviews generated under the 2007 rules, these newer reviews rely on fewer references, incorporate less expert input, are more likely to be based exclusively on gray literature, and are no longer required either to provide dissemination readiness information or meet certain minimum research quality standards. However, only 123 (25.7%) of the 479 Registry interventions have been reviewed solely using the problematic 2015 criteria, with the remaining 356 interventions having a review which use the 2007 guidelines. Yet, rather than address the agency’s recent missteps and expand the Registry’s content coverage, the agency appears to have decided to invest considerable resources into replacing it, relying heavily on expert consensus versus empirical data in its initial attempt to do so. This raises questions about the agency’s current commitment to evidence-based practice.
机译:最近,美国精神卫生和物质使用助理部长透露,已暂停国家循证计划和实践国家注册局,指出其严格性和广度不足,必须予以更换。但是,仔细检查她有关注册表的说法表明其中许多是不准确的。与她的主张相反,书记官处并非没有使用阿片类药物的药物辅助疗法;它也没有包含与精神分裂症和精神病有关的很少干预措施。此外,她对严谨性的许多批评都与自2015年底以来的审查有关,当时药物滥用和精神卫生服务管理局更改了注册表的关键方面。与根据2007年规则生成的审阅相比,这些较新的审阅依赖较少的参考文献,较少的专家意见,更有可能完全基于灰色文献,并且不再需要提供传播准备信息或满足某些最低限度的研究要求质量标准。但是,仅使用有问题的2015年标准仅审查了479个注册管理机构干预措施中的123个(25.7%),其余356个干预措施使用了2007年指南进行了审核。然而,该机构似乎没有决定解决机构最近的失误并扩大注册管理机构的内容覆盖范围,而是决定投入大量资源来替换其,而是在最初尝试中主要依靠专家共识和经验数据。这使人们对该机构目前对循证实践的承诺提出了质疑。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号